Phesi and Sensyne to collaborate on synthetic control arms for clinical trials
Drug development-focused artificial intelligence (AI) analytics company Phesi has signed an exclusive strategic collaboration with UK-based Sensyne Health. In addition,…
Drug development-focused artificial intelligence (AI) analytics company Phesi has signed an exclusive strategic collaboration with UK-based Sensyne Health. In addition,…
Massachusetts-based Immuneering Corporation has closed an oversubscribed $62m Series B round. The financing was led by Cormorant Asset Management. Surveyor…
Sanofi has signed an agreement to acquire clinical-stage biopharmaceutical company Kymab for an upfront payment of about $1.1bn in cash. The deal also includes payment…
Merck has announced the acquisition of Germany-based, mRNA contract development and manufacturing organisation (CDMO) AmpTec. The deal will enhance Merck’s expertise in developing and manufacturing…
Eli Lilly and Company has entered a definitive agreement to acquire biotechnology company Prevail Therapeutics for a total consideration of…
AstraZeneca has signed a definitive agreement to acquire global biopharmaceutical company Alexion Pharmaceuticals for $39bn or $175 a share. According…
Boehringer Ingelheim has signed a binding agreement to acquire all shares of clinical-stage Swiss biotechnology company NBE-Therapeutics for a total…
Gilead Sciences has signed a definitive agreement to acquire German biotechnology company MYR for approximately €1.15bn ($1.4bn) in cash. According…
Precision medicine-focused Frontier Medicines has signed a multi-year collaboration with AbbVie to discover, develop and commercialise multiple small molecule therapeutics…
UK-based artificial intelligence (AI) drug discovery company Exscientia has received a $4.2m two-year grant from the Bill and Melinda Gates…
Pre-filled syringes are regarded as one of the most effective medical devices of administering medications to patients. The rapidly increasing…
Cytiva opened a new facility for manufacturing Xcellerex XDR bioreactors in Shrewsbury, Massachusetts, US, in December 2020. The new manufacturing…
Last year, there was significant focus on the pharmaceutical industry as the race for Covid-19 treatments and vaccine began. With…
OpenClinica is pleased to announce that it will be featured on public television series In Depth, showcasing its clinical trials…